Wound Management Technologies, Inc. | ||
(Exact name of registrant as specified in its charter) | ||
Texas | 000-11808 | 59-2219994 |
(State or other jurisdiction | (Commission File | (IRS Employer |
incorporation) | Number) | Identification No.) |
16633 Dallas Parkway, Suite 250, Addison, Texas 75001 | ||
(Address of principal executive offices) (Zip Code) | ||
Registrant’s telephone number, including area code | 972-218-0935 |
[_]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[_]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[_]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[_]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
(a)
|
On September 3, 2014, Wound Management Technologies, Inc. (the “Company”) held its Annual Meeting of Stockholders.
|
(b)
|
The following table presents the final voting results for the items that were presented for stockholder approval.
|
For
|
Against
|
Abstain
|
Broker Non-vote
|
|||||||||||||
(1) To elect to the Wound Management Board of Directors until the next annual meeting of shareholders:
|
||||||||||||||||
Robert Lutz, Jr.
|
94,434,032 | 2,248,382 | 20,005 | 26,539,582 | ||||||||||||
Philip J. Rubinfeld
|
88,181,134 | 8,501,281 | 20,005 | 26,539,582 | ||||||||||||
John Feltman
|
88,191,134 | 8,491,280 | 20,005 | 26,539,582 | ||||||||||||
Ronald Goode
|
94,441,128 | 2,241,286 | 20,005 | 26,539,582 | ||||||||||||
Jeff Lewis
|
94,441,133 | 2,241,281 | 20,005 | 26,539,582 | ||||||||||||
(2) To ratify the appointment of Malone Bailey LLP as Wound Management’s independent registered public accounting firm for the year ending December 31, 2014.
|
119,304,468 | 11,627 | 91,747 |
__
|
||||||||||||
(3) To adopt an amendment to the Company’s Articles of Incorporation to increase the authorized shares of common stock of the Company from 100,000,000 to 250,000,000.
|
113,780,945 | 3,746,432 | 602,015 | 5,507,648 | ||||||||||||
(4) To authorize the filing, within the next twelve months of an additional amendment to the Company’s Articles of Incorporation effecting a 1-for-10 reverse split of the Company’s common stock.
|
113,040,722 | 6,367,106 | 12 | 4,229,200 | ||||||||||||
(5) To approve the adoption of the Company’s 2014 Stock Incentive Plan.
|
87,582,806 | 9,119,609 | 4 | 26,539,582 | ||||||||||||
(6) To approve, by advisory vote, a resolution on executive compensation.
|
87,925,407 | 8,777,008 | 4 | 26,539,582 | ||||||||||||
One Year
|
Two Years
|
Three Years
|
Abstain
|
|||||||||||||
(7) Recommend, by advisory vote, the frequency of future advisory votes on executive compensation.
|
4,596,043 | 6,735,453 | 82,400,561 | 2,963,855 |
WOUND MANAGEMENT TECHNOLOGIES, INC. | |||
Date: September 8, 2014
|
By:
|
/s/ Darren Stine, Chief Financial Officer | |
Darren Stine, Chief Financial Officer
|
|||